Tension Band Versus Locking Plate Fixation for the Treatment of Patella Fractures
Launched by RASMUS ELSØE · May 13, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two different surgical methods for fixing patella fractures, which are breaks in the kneecap. The two methods being studied are called tension band fixation and locking plate fixation. The goal is to see which method works better for healing these types of fractures. The trial is currently looking for participants, specifically adults over 18 years old who have a suitable patella fracture that can be treated with either method.
To be eligible for the study, participants should not have certain conditions, such as multiple fractures in the same leg or previous surgeries on the same knee. If you join the trial, you'll be randomly assigned to receive one of the two treatment options, and your progress will be closely monitored by medical professionals. This study aims to help improve treatment options for patella fractures, so it could be an important opportunity for those affected by this injury.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Above 18 years of age
- • Patella fracture suitable for surgically treatment, with both surgical methods
- • AO classification 34-B, 34-C
- Exclusion Criteria:
- • Open patella fracture above Gustillo grade 2
- • Bilateral patella fracture
- • Total knee replacement in the affected extremity
- • Other fractures of the affected extremity within the previous 12 months.
- • Other reasons for exclusion (unable to understand Danish, mentally unable to participate, etc).
- • Prior ipsilateral patella fracture
About Rasmus Elsøe
Rasmus Elsøe is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and rigorous scientific methodologies, Rasmus leads initiatives that encompass various therapeutic areas, ensuring compliance with regulatory standards and ethical guidelines. Through collaboration with healthcare professionals and research institutions, Rasmus Elsøe aims to facilitate the development of safe and effective treatments, contributing to the enhancement of global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aalborg, , Denmark
Aarhus, , Denmark
Viborg, , Denmark
Randers, , Denmark
Hjørring, , Denmark
Kolding, , Denmark
Patients applied
Trial Officials
Rasmus Elsoe, MD, PhD
Study Chair
Aalborg University Hospital, Denmark
Peter Larsen, PT, PhD
Principal Investigator
Aalborg University Hospital, Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials